Cargando…

The application of epiphenotyping approaches to DNA methylation array studies of the human placenta

BACKGROUND: Genome-wide DNA methylation (DNAme) profiling of the placenta with Illumina Infinium Methylation bead arrays is often used to explore the connections between in utero exposures, placental pathology, and fetal development. However, many technical and biological factors can lead to signals...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Almas, Inkster, Amy M, Peñaherrera, Maria S, King, Suzanne, Kildea, Sue, Oberlander, Tim F, Olson, David M, Vaillancourt, Cathy, Brain, Ursula, Beraldo, Ella O, Beristain, Alexander G, Clifton, Vicki L, Del Gobbo, Giulia F, Lam, Wan L, Metz, Gerlinde AS, Ng, Jane WY, Price, E Magda, Schuetz, Johanna M, Yuan, Victor, Portales-Casamar, Élodie, Robinson, Wendy P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350117/
https://www.ncbi.nlm.nih.gov/pubmed/37461679
http://dx.doi.org/10.21203/rs.3.rs-3069705/v1
_version_ 1785074062714732544
author Khan, Almas
Inkster, Amy M
Peñaherrera, Maria S
King, Suzanne
Kildea, Sue
Oberlander, Tim F
Olson, David M
Vaillancourt, Cathy
Brain, Ursula
Beraldo, Ella O
Beristain, Alexander G
Clifton, Vicki L
Del Gobbo, Giulia F
Lam, Wan L
Metz, Gerlinde AS
Ng, Jane WY
Price, E Magda
Schuetz, Johanna M
Yuan, Victor
Portales-Casamar, Élodie
Robinson, Wendy P
author_facet Khan, Almas
Inkster, Amy M
Peñaherrera, Maria S
King, Suzanne
Kildea, Sue
Oberlander, Tim F
Olson, David M
Vaillancourt, Cathy
Brain, Ursula
Beraldo, Ella O
Beristain, Alexander G
Clifton, Vicki L
Del Gobbo, Giulia F
Lam, Wan L
Metz, Gerlinde AS
Ng, Jane WY
Price, E Magda
Schuetz, Johanna M
Yuan, Victor
Portales-Casamar, Élodie
Robinson, Wendy P
author_sort Khan, Almas
collection PubMed
description BACKGROUND: Genome-wide DNA methylation (DNAme) profiling of the placenta with Illumina Infinium Methylation bead arrays is often used to explore the connections between in utero exposures, placental pathology, and fetal development. However, many technical and biological factors can lead to signals of DNAme variation between samples and between cohorts, and understafinding and accounting for these factors is essential to ensure meaningful and replicable data analysis. Recently, “epiphenotyping” approaches have been developed whereby DNAme data can be used to impute information about phenotypic variables such as gestational age, sex, cell composition, and ancestry. These epiphenotypes offer avenues to compare phenotypic data across cohorts, and to understand how phenotypic variables relate to DNAme variability. However, the relationships between placental epiphenotyping variables and other technical and biological variables, and their application to downstream epigenome analyses, have not been well studied. RESULTS: Using DNAme data from 204 placentas across three cohorts, we applied the PlaNET R package to estimate epiphenotypes gestational age, ancestry, and cell composition in these samples. PlaNET ancestry estimates were highly correlated with independent polymorphic ancestry informative markers, and epigenetic gestational age, on average, was estimated within 4 days of reported gestational age, underscoring the accuracy of these tools. Cell composition estimates varied both within and between cohorts, but reassuringly were robust to placental processing time. Interestingly, the ratio of cytotrophoblast to syncytiotrophoblast proportion decreased with increasing gestational age, and differed slightly by both maternal ethnicity (lower in white vs. non-white) and genetic ancestry (lower in higher probability European ancestry). The cohort of origin and cytotrophoblast proportion were the largest drivers of DNAme variation in this dataset, based on their associations with the first principal component. CONCLUSIONS: This work confirms that cohort, array (technical) batch, cell type proportion, self-reported ethnicity, genetic ancestry, and biological sex are important variables to consider in any analyses of Illumina DNAme data. Further, we demonstrate that estimating epiphenotype variables from the DNAme data itself, when possible, provides both an independent check of clinically-obtained data and can provide a robust approach to compare variables across different datasets.
format Online
Article
Text
id pubmed-10350117
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-103501172023-07-17 The application of epiphenotyping approaches to DNA methylation array studies of the human placenta Khan, Almas Inkster, Amy M Peñaherrera, Maria S King, Suzanne Kildea, Sue Oberlander, Tim F Olson, David M Vaillancourt, Cathy Brain, Ursula Beraldo, Ella O Beristain, Alexander G Clifton, Vicki L Del Gobbo, Giulia F Lam, Wan L Metz, Gerlinde AS Ng, Jane WY Price, E Magda Schuetz, Johanna M Yuan, Victor Portales-Casamar, Élodie Robinson, Wendy P Res Sq Article BACKGROUND: Genome-wide DNA methylation (DNAme) profiling of the placenta with Illumina Infinium Methylation bead arrays is often used to explore the connections between in utero exposures, placental pathology, and fetal development. However, many technical and biological factors can lead to signals of DNAme variation between samples and between cohorts, and understafinding and accounting for these factors is essential to ensure meaningful and replicable data analysis. Recently, “epiphenotyping” approaches have been developed whereby DNAme data can be used to impute information about phenotypic variables such as gestational age, sex, cell composition, and ancestry. These epiphenotypes offer avenues to compare phenotypic data across cohorts, and to understand how phenotypic variables relate to DNAme variability. However, the relationships between placental epiphenotyping variables and other technical and biological variables, and their application to downstream epigenome analyses, have not been well studied. RESULTS: Using DNAme data from 204 placentas across three cohorts, we applied the PlaNET R package to estimate epiphenotypes gestational age, ancestry, and cell composition in these samples. PlaNET ancestry estimates were highly correlated with independent polymorphic ancestry informative markers, and epigenetic gestational age, on average, was estimated within 4 days of reported gestational age, underscoring the accuracy of these tools. Cell composition estimates varied both within and between cohorts, but reassuringly were robust to placental processing time. Interestingly, the ratio of cytotrophoblast to syncytiotrophoblast proportion decreased with increasing gestational age, and differed slightly by both maternal ethnicity (lower in white vs. non-white) and genetic ancestry (lower in higher probability European ancestry). The cohort of origin and cytotrophoblast proportion were the largest drivers of DNAme variation in this dataset, based on their associations with the first principal component. CONCLUSIONS: This work confirms that cohort, array (technical) batch, cell type proportion, self-reported ethnicity, genetic ancestry, and biological sex are important variables to consider in any analyses of Illumina DNAme data. Further, we demonstrate that estimating epiphenotype variables from the DNAme data itself, when possible, provides both an independent check of clinically-obtained data and can provide a robust approach to compare variables across different datasets. American Journal Experts 2023-06-26 /pmc/articles/PMC10350117/ /pubmed/37461679 http://dx.doi.org/10.21203/rs.3.rs-3069705/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Khan, Almas
Inkster, Amy M
Peñaherrera, Maria S
King, Suzanne
Kildea, Sue
Oberlander, Tim F
Olson, David M
Vaillancourt, Cathy
Brain, Ursula
Beraldo, Ella O
Beristain, Alexander G
Clifton, Vicki L
Del Gobbo, Giulia F
Lam, Wan L
Metz, Gerlinde AS
Ng, Jane WY
Price, E Magda
Schuetz, Johanna M
Yuan, Victor
Portales-Casamar, Élodie
Robinson, Wendy P
The application of epiphenotyping approaches to DNA methylation array studies of the human placenta
title The application of epiphenotyping approaches to DNA methylation array studies of the human placenta
title_full The application of epiphenotyping approaches to DNA methylation array studies of the human placenta
title_fullStr The application of epiphenotyping approaches to DNA methylation array studies of the human placenta
title_full_unstemmed The application of epiphenotyping approaches to DNA methylation array studies of the human placenta
title_short The application of epiphenotyping approaches to DNA methylation array studies of the human placenta
title_sort application of epiphenotyping approaches to dna methylation array studies of the human placenta
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350117/
https://www.ncbi.nlm.nih.gov/pubmed/37461679
http://dx.doi.org/10.21203/rs.3.rs-3069705/v1
work_keys_str_mv AT khanalmas theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT inksteramym theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT penaherreramarias theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT kingsuzanne theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT kildeasue theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT oberlandertimf theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT olsondavidm theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT vaillancourtcathy theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT brainursula theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT beraldoellao theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT beristainalexanderg theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT cliftonvickil theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT delgobbogiuliaf theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT lamwanl theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT metzgerlindeas theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT ngjanewy theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT priceemagda theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT schuetzjohannam theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT yuanvictor theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT portalescasamarelodie theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT robinsonwendyp theapplicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT khanalmas applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT inksteramym applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT penaherreramarias applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT kingsuzanne applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT kildeasue applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT oberlandertimf applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT olsondavidm applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT vaillancourtcathy applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT brainursula applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT beraldoellao applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT beristainalexanderg applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT cliftonvickil applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT delgobbogiuliaf applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT lamwanl applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT metzgerlindeas applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT ngjanewy applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT priceemagda applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT schuetzjohannam applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT yuanvictor applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT portalescasamarelodie applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta
AT robinsonwendyp applicationofepiphenotypingapproachestodnamethylationarraystudiesofthehumanplacenta